Reata, Dycom rise; Novavax, Ambarella fall
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Wednesday:
Monster Beverage Corp., down $2.57 to $99.19.
The energy drink maker reported weak fourth-quarter results.
Ambarella Inc., down $10.84 to $83.47.
The video-compression chipmaker's revenue forecast fell short of Wall Street expectations.
Novavax Inc., down $2.40 to $6.86.
The vaccine maker warned investors about its ability to remain in business.
Payoneer Global Inc., up 80 cents to $6.60.
The global payments company gave investors a strong revenue forecast.
Reata Pharmaceuticals Inc., up $62 to $93.17.
The biopharmaceutical company's treatment for Friedreich’s ataxia, a rare disease, received U.S. regulatory approval.
Dycom Industries Inc., up $12.81 to $97.02.
The provider of specialty contracting services reported strong fourth-quarter financial results.
First Solar Inc., up $26.54 to $195.68.
The solar power systems company beat analysts' fourth-quarter earnings forecasts.
Sarepta Therapeutics Inc., up $23.50 to $145.63.
The biopharmaceutical company’s fourth-quarter earnings and revenue beat analysts’ forecasts.
Provided Content: Content provided by Associated Press. The Globe and Mail was not involved, and material was not reviewed prior to publication.
